Hisamitsu Pharmaceutical Co., Inc. (4530.T)

JPY 4086.0

(-0.61%)

Long Term Debt Summary of Hisamitsu Pharmaceutical Co., Inc.

  • Hisamitsu Pharmaceutical Co., Inc.'s latest annual long term debt in 2023 was 76 Million JPY , down -91.53% from previous year.
  • Hisamitsu Pharmaceutical Co., Inc.'s latest quarterly long term debt in 2024 Q2 was 46 Million JPY , down -22.03% from previous quarter.
  • Hisamitsu Pharmaceutical Co., Inc. reported annual long term debt of 897 Million JPY in 2022, down -17.56% from previous year.
  • Hisamitsu Pharmaceutical Co., Inc. reported annual long term debt of 1.08 Billion JPY in 2021, up 178.97% from previous year.
  • Hisamitsu Pharmaceutical Co., Inc. reported quarterly long term debt of 46 Million JPY for 2024 Q2, down -22.03% from previous quarter.
  • Hisamitsu Pharmaceutical Co., Inc. reported quarterly long term debt of 76 Million JPY for 2023 FY, down -91.53% from previous quarter.

Annual Long Term Debt Chart of Hisamitsu Pharmaceutical Co., Inc. (2023 - 2004)

Historical Annual Long Term Debt of Hisamitsu Pharmaceutical Co., Inc. (2023 - 2004)

Year Long Term Debt Long Term Debt Growth
2023 76 Million JPY -91.53%
2022 897 Million JPY -17.56%
2021 1.08 Billion JPY 178.97%
2020 390 Million JPY -21.69%
2019 498 Million JPY -0.99%
2018 503 Million JPY -11.44%
2017 568 Million JPY -6.58%
2016 608 Million JPY -11.76%
2015 689 Million JPY -12.56%
2014 788 Million JPY -21.83%
2013 1 Billion JPY -18.31%
2012 1.23 Billion JPY -19.24%
2011 1.52 Billion JPY -55.89%
2010 3.46 Billion JPY -58.2%
2009 8.28 Billion JPY 840.64%
2008 881 Million JPY 4.63%
2007 842 Million JPY -20.42%
2006 1.05 Billion JPY -70.19%
2005 3.54 Billion JPY 158.49%
2004 1.37 Billion JPY 0.0%

Peer Long Term Debt Comparison of Hisamitsu Pharmaceutical Co., Inc.

Name Long Term Debt Long Term Debt Difference
Pharma Foods International Co., Ltd. 1.23 Billion JPY 93.826%
Takeda Pharmaceutical Company Limited 4476.5 Billion JPY 99.998%
Sumitomo Pharma Co., Ltd. 133.36 Billion JPY 99.943%
Shionogi & Co., Ltd. 8.75 Billion JPY 99.132%
Wakamoto Pharmaceutical Co.,Ltd. - JPY -Infinity%
Nippon Shinyaku Co., Ltd. 1.15 Billion JPY 93.403%
Kaken Pharmaceutical Co., Ltd. - JPY -Infinity%
Eisai Co., Ltd. 134.77 Billion JPY 99.944%
Morishita Jintan Co., Ltd. 106 Million JPY 28.302%
Mochida Pharmaceutical Co., Ltd. - JPY -Infinity%
Fuso Pharmaceutical Industries,Ltd. 7.02 Billion JPY 98.918%
Nippon Chemiphar Co., Ltd. 13.34 Billion JPY 99.43%
Tsumura & Co. 54.37 Billion JPY 99.86%
Kissei Pharmaceutical Co., Ltd. - JPY -Infinity%
Torii Pharmaceutical Co., Ltd. 22 Million JPY -245.455%
Towa Pharmaceutical Co., Ltd. 189.12 Billion JPY 99.96%
Fuji Pharma Co., Ltd. 11.92 Billion JPY 99.363%
Zeria Pharmaceutical Co., Ltd. 7.94 Billion JPY 99.043%
KYORIN Holdings, Inc. 435 Million JPY 82.529%
Taiko Pharmaceutical Co.,Ltd. 2.74 Billion JPY 97.227%
Daito Pharmaceutical Co.,Ltd. 4.66 Billion JPY 98.372%
SymBio Pharmaceuticals Limited - JPY -Infinity%
MedRx Co., Ltd - JPY -Infinity%
Mizuho Medy Co.,Ltd. - JPY -Infinity%
Solasia Pharma K.K. 27 Million JPY -181.481%
Modalis Therapeutics Corporation 412.5 Million JPY 81.576%
ASKA Pharmaceutical Holdings Co.,Ltd. 4.5 Billion JPY 98.313%
Sawai Group Holdings Co., Ltd. 66.84 Billion JPY 99.886%
Cyfuse Biomedical K.K. 345 Million JPY 77.971%
Toho Holdings Co., Ltd. 28.16 Billion JPY 99.73%
Koa Shoji Holdings Co.,Ltd. 1.59 Billion JPY 95.224%